Preclinical episodes of orofacial pain symptoms and their association with health care behaviors in the OPPERA prospective cohort study

Gary D. Slade, Anne E. Sanders, Eric Bair, Naomi Brownstein, Dawn Dampier, Charles Knott, Roger Fillingim, William O. Maixner, Shad Smith, Joel Daniel Greenspan, Ron Dubner, Richard Ohrbach

Research output: Contribution to journalArticle

Abstract

The course of preclinical pain symptoms sheds light on the etiology and prognosis of chronic pain. We aimed to quantify rates of developing initial and recurrent symptoms of painful temporomandibular disorder (TMD) and to evaluate associations with health behaviors. In the OPPERA prospective cohort study, 2,719 individuals aged 18 to 44 years with lifetime absence of TMD when enrolled completed 25,103 quarterly (3-monthly) questionnaires during a median 2.3-year follow-up period. Questionnaires documented TMD symptom episodes, headache, other body pain, health care attendance, and analgesic use, and. Kaplan-Meier methods for clustered data estimated symptom-free survival time. Multivariable models assessed demographic variation in TMD symptom rates and evaluated associations with health care and analgesic use. One-third of the study subjects developed TMD symptoms and for a quarter of symptomatic episodes, pain intensity was severe. Initial TMD symptoms developed at an annual rate of 18.8 episodes per 100 persons. The annual rate more than doubled for first-recurrence and doubled again for second or subsequent recurrence such that, 1 year after first recurrence, 71% of study subjects experienced a second recurrence. The overall rate increased with age and was greater in African Americans and lower in Asians relative to those of white race/ethnicity. The probability of TMD symptoms was strongly associated with concurrent episodes of headache and body pain and with past episodes of TMD symptoms. Episodes of TMD symptoms, headache, and body pain were associated with increases of 10% in probability of analgesic use and health care attendance. Yet, even when TMD, headache, and body pain occurred concurrently, 27% of study subjects neither attended health care nor used analgesics.

Original languageEnglish (US)
Pages (from-to)750-760
Number of pages11
JournalPain
Volume154
Issue number5
DOIs
StatePublished - May 2013
Externally publishedYes

Fingerprint

Temporomandibular Joint Disorders
Facial Pain
Cohort Studies
Prospective Studies
Delivery of Health Care
Pain
Headache
Analgesics
Recurrence
Health Behavior
Chronic Pain
African Americans
Demography

Keywords

  • Epidemiology
  • Health behavior
  • Pain symptoms
  • Prospective cohort study
  • Temporomandibular disorder

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine
  • Neurology
  • Pharmacology

Cite this

Slade, G. D., Sanders, A. E., Bair, E., Brownstein, N., Dampier, D., Knott, C., ... Ohrbach, R. (2013). Preclinical episodes of orofacial pain symptoms and their association with health care behaviors in the OPPERA prospective cohort study. Pain, 154(5), 750-760. https://doi.org/10.1016/j.pain.2013.01.014

Preclinical episodes of orofacial pain symptoms and their association with health care behaviors in the OPPERA prospective cohort study. / Slade, Gary D.; Sanders, Anne E.; Bair, Eric; Brownstein, Naomi; Dampier, Dawn; Knott, Charles; Fillingim, Roger; Maixner, William O.; Smith, Shad; Greenspan, Joel Daniel; Dubner, Ron; Ohrbach, Richard.

In: Pain, Vol. 154, No. 5, 05.2013, p. 750-760.

Research output: Contribution to journalArticle

Slade, GD, Sanders, AE, Bair, E, Brownstein, N, Dampier, D, Knott, C, Fillingim, R, Maixner, WO, Smith, S, Greenspan, JD, Dubner, R & Ohrbach, R 2013, 'Preclinical episodes of orofacial pain symptoms and their association with health care behaviors in the OPPERA prospective cohort study', Pain, vol. 154, no. 5, pp. 750-760. https://doi.org/10.1016/j.pain.2013.01.014
Slade, Gary D. ; Sanders, Anne E. ; Bair, Eric ; Brownstein, Naomi ; Dampier, Dawn ; Knott, Charles ; Fillingim, Roger ; Maixner, William O. ; Smith, Shad ; Greenspan, Joel Daniel ; Dubner, Ron ; Ohrbach, Richard. / Preclinical episodes of orofacial pain symptoms and their association with health care behaviors in the OPPERA prospective cohort study. In: Pain. 2013 ; Vol. 154, No. 5. pp. 750-760.
@article{27d874dc841a437ea32518e4e3afc4a4,
title = "Preclinical episodes of orofacial pain symptoms and their association with health care behaviors in the OPPERA prospective cohort study",
abstract = "The course of preclinical pain symptoms sheds light on the etiology and prognosis of chronic pain. We aimed to quantify rates of developing initial and recurrent symptoms of painful temporomandibular disorder (TMD) and to evaluate associations with health behaviors. In the OPPERA prospective cohort study, 2,719 individuals aged 18 to 44 years with lifetime absence of TMD when enrolled completed 25,103 quarterly (3-monthly) questionnaires during a median 2.3-year follow-up period. Questionnaires documented TMD symptom episodes, headache, other body pain, health care attendance, and analgesic use, and. Kaplan-Meier methods for clustered data estimated symptom-free survival time. Multivariable models assessed demographic variation in TMD symptom rates and evaluated associations with health care and analgesic use. One-third of the study subjects developed TMD symptoms and for a quarter of symptomatic episodes, pain intensity was severe. Initial TMD symptoms developed at an annual rate of 18.8 episodes per 100 persons. The annual rate more than doubled for first-recurrence and doubled again for second or subsequent recurrence such that, 1 year after first recurrence, 71{\%} of study subjects experienced a second recurrence. The overall rate increased with age and was greater in African Americans and lower in Asians relative to those of white race/ethnicity. The probability of TMD symptoms was strongly associated with concurrent episodes of headache and body pain and with past episodes of TMD symptoms. Episodes of TMD symptoms, headache, and body pain were associated with increases of 10{\%} in probability of analgesic use and health care attendance. Yet, even when TMD, headache, and body pain occurred concurrently, 27{\%} of study subjects neither attended health care nor used analgesics.",
keywords = "Epidemiology, Health behavior, Pain symptoms, Prospective cohort study, Temporomandibular disorder",
author = "Slade, {Gary D.} and Sanders, {Anne E.} and Eric Bair and Naomi Brownstein and Dawn Dampier and Charles Knott and Roger Fillingim and Maixner, {William O.} and Shad Smith and Greenspan, {Joel Daniel} and Ron Dubner and Richard Ohrbach",
year = "2013",
month = "5",
doi = "10.1016/j.pain.2013.01.014",
language = "English (US)",
volume = "154",
pages = "750--760",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Preclinical episodes of orofacial pain symptoms and their association with health care behaviors in the OPPERA prospective cohort study

AU - Slade, Gary D.

AU - Sanders, Anne E.

AU - Bair, Eric

AU - Brownstein, Naomi

AU - Dampier, Dawn

AU - Knott, Charles

AU - Fillingim, Roger

AU - Maixner, William O.

AU - Smith, Shad

AU - Greenspan, Joel Daniel

AU - Dubner, Ron

AU - Ohrbach, Richard

PY - 2013/5

Y1 - 2013/5

N2 - The course of preclinical pain symptoms sheds light on the etiology and prognosis of chronic pain. We aimed to quantify rates of developing initial and recurrent symptoms of painful temporomandibular disorder (TMD) and to evaluate associations with health behaviors. In the OPPERA prospective cohort study, 2,719 individuals aged 18 to 44 years with lifetime absence of TMD when enrolled completed 25,103 quarterly (3-monthly) questionnaires during a median 2.3-year follow-up period. Questionnaires documented TMD symptom episodes, headache, other body pain, health care attendance, and analgesic use, and. Kaplan-Meier methods for clustered data estimated symptom-free survival time. Multivariable models assessed demographic variation in TMD symptom rates and evaluated associations with health care and analgesic use. One-third of the study subjects developed TMD symptoms and for a quarter of symptomatic episodes, pain intensity was severe. Initial TMD symptoms developed at an annual rate of 18.8 episodes per 100 persons. The annual rate more than doubled for first-recurrence and doubled again for second or subsequent recurrence such that, 1 year after first recurrence, 71% of study subjects experienced a second recurrence. The overall rate increased with age and was greater in African Americans and lower in Asians relative to those of white race/ethnicity. The probability of TMD symptoms was strongly associated with concurrent episodes of headache and body pain and with past episodes of TMD symptoms. Episodes of TMD symptoms, headache, and body pain were associated with increases of 10% in probability of analgesic use and health care attendance. Yet, even when TMD, headache, and body pain occurred concurrently, 27% of study subjects neither attended health care nor used analgesics.

AB - The course of preclinical pain symptoms sheds light on the etiology and prognosis of chronic pain. We aimed to quantify rates of developing initial and recurrent symptoms of painful temporomandibular disorder (TMD) and to evaluate associations with health behaviors. In the OPPERA prospective cohort study, 2,719 individuals aged 18 to 44 years with lifetime absence of TMD when enrolled completed 25,103 quarterly (3-monthly) questionnaires during a median 2.3-year follow-up period. Questionnaires documented TMD symptom episodes, headache, other body pain, health care attendance, and analgesic use, and. Kaplan-Meier methods for clustered data estimated symptom-free survival time. Multivariable models assessed demographic variation in TMD symptom rates and evaluated associations with health care and analgesic use. One-third of the study subjects developed TMD symptoms and for a quarter of symptomatic episodes, pain intensity was severe. Initial TMD symptoms developed at an annual rate of 18.8 episodes per 100 persons. The annual rate more than doubled for first-recurrence and doubled again for second or subsequent recurrence such that, 1 year after first recurrence, 71% of study subjects experienced a second recurrence. The overall rate increased with age and was greater in African Americans and lower in Asians relative to those of white race/ethnicity. The probability of TMD symptoms was strongly associated with concurrent episodes of headache and body pain and with past episodes of TMD symptoms. Episodes of TMD symptoms, headache, and body pain were associated with increases of 10% in probability of analgesic use and health care attendance. Yet, even when TMD, headache, and body pain occurred concurrently, 27% of study subjects neither attended health care nor used analgesics.

KW - Epidemiology

KW - Health behavior

KW - Pain symptoms

KW - Prospective cohort study

KW - Temporomandibular disorder

UR - http://www.scopus.com/inward/record.url?scp=84878019014&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878019014&partnerID=8YFLogxK

U2 - 10.1016/j.pain.2013.01.014

DO - 10.1016/j.pain.2013.01.014

M3 - Article

C2 - 23531476

AN - SCOPUS:84878019014

VL - 154

SP - 750

EP - 760

JO - Pain

JF - Pain

SN - 0304-3959

IS - 5

ER -